Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Alkermes Contract Pharma Services

Product Description

Alkermes Contract Pharma Services is a leading provider of solid dosage form product development, scale-up and manufacturing services for the pharmaceutical market. With over 40 years experience and innovation, previously as Elan Drug Technologies, we continue to be the outsourcing partner of choice for over 30 leading pharmaceutical companies. 

All the services we offer to our clients are provided with the greatest attention to quality and customer service. Our manufacturing business is driven by ‘excellence in everything we do’, which through our Operational Excellence program, gives you the reassurance that your product will be guided through our facilities to exacting specifications.

Key Benefits

• Experience and expertise:
          - 40+ year history in business with proven track record

• The industry trusts us:
          - 30+ leading pharma companies are partners of ours

• Wide range of services sets us apart:
         - Effective, robust and swift technical transfers
         - Range of proven and validated process improvement solutions
         - Modern facilities with best in class systems
         - Competitive pricing
         - On-time delivery record
         - Exceptional compliance track record
         - Excellent environmental, health and safety record

• FDA/EMA-licensed sites in both Europe and U.S. (and other territories including supply of product to Brazil, China and India).

Product Alkermes Contract Pharma Services
Company Alkermes
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Alkermes
Monksland, Athlone, Co Westmeath, Ireland

Tel: +353 9064 95000

Email: contract@alkermes.com



Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!